Us Anti-Neprilysin Antibody Market Size By Applications, By Type, By End-User, By Deployment & By Technology 2032
Anti-Neprilysin Antibody Market was valued at USD 0.45 Billion in 2022 and is projected to reach USD 1.25 Billion by 2030, growing at a CAGR of 17.5% from 2024 to 2030.
The U.S. Anti-Neprilysin Antibody Market is experiencing significant growth, driven by the increasing prevalence of chronic diseases and advancements in biotechnology. Neprilysin, an enzyme responsible for degrading natriuretic peptides, plays a crucial role in the pathophysiology of heart failure and hypertension. Inhibiting this enzyme has shown promising potential in managing these conditions, leading to a surge in demand for anti-neprilysin antibodies. Projections estimate the global anti-neprilysin antibody market to reach USD 2.8 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.5% during the forecast period. The U.S. market, being a significant contributor, is expected to mirror this growth trajectory. citeturn0search0 The market is segmented based on product type, application, and end-user. Product types include monoclonal and polyclonal antibodies. Applications encompass research, therapeutics, and diagnostics. End-users comprise pharmaceutical and biotechnology companies, academic and research institutes, and diagnostic laboratories. citeturn0search0 In the therapeutic segment, anti-neprilysin antibodies are being explored for their potential in treating heart failure and hypertension. The diagnostic segment benefits from these antibodies' ability to detect neprilysin levels, aiding in the early diagnosis of related cardiovascular conditions. Key players in the U.S. market include Bioprojet SCR, Novartis International AG, Pharmaleads SA, Theravance Biopharma Inc., Cipla Limited, and Oceanic Pharmachem Pvt. Ltd. These companies are actively involved in developing and commercializing anti-neprilysin antibody-based products. citeturn0search3 The increasing demand for targeted therapies and the rising prevalence of chronic diseases are expected to drive the market's growth. Additionally, advancements in biotechnology and the development of new manufacturing facilities are anticipated to further boost the market. For instance, Cipla Inc. announced the commercial operation of additional capacity of captive renewable energy power plants in Maharashtra and Karnataka, India, which is expected to enhance production capabilities. citeturn0search6 In summary, the U.S. Anti-Neprilysin Antibody Market is poised for substantial growth, driven by the increasing demand for targeted therapies and advancements in biotechnology. The market's expansion is expected to continue, offering significant opportunities for stakeholders in the healthcare and biotechnology sectors.
Get an In-Depth Research Analysis of the Global Anti-Neprilysin Antibody Market Size And Forecast [2025-2032]
Bioprojet SCR
Novartis International AG
Pharmaleads SA
Theravance Biopharma Inc.
Cipla Limited
Oceanic Pharmachem Pvt. Ltd
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Anti-Neprilysin Antibody Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Anti-Neprilysin Antibody Market
Monoclonal Antibodies
Polyclonal Antibodies
Recombinant Antibodies
Fab Fragments
Research and Development
Diagnostic Applications
Therapeutic Applications
Clinical Trials
Pharmaceutical Companies
Biotechnology Companies
Academic and Research Institutes
Contract Research Organizations (CROs)
Online Distribution
Offline Distribution
Direct Sales
Third-Party Distributors
Cardiovascular Diseases
Neurodegenerative Disorders
Oncology
Other Chronic Diseases
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Anti-Neprilysin Antibody Market Research Analysis
1. Introduction of the Global Anti-Neprilysin Antibody Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Anti-Neprilysin Antibody Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Anti-Neprilysin Antibody Market, By Type
6. Global Anti-Neprilysin Antibody Market, By Application
7. Global Anti-Neprilysin Antibody Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Anti-Neprilysin Antibody Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/